ARCHIVES

New Technology May Enable Therapy Tailored To Patient’s Predicted Response

This article is from The Cancer Letter archive.

Vol. 25 No. 4 | April 26, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Kenneth Olden Named Director Of Howard Cancer Center; Calhoon Sparked AMA On Cigarette Ads

February 21, 1986

Clolar Approved for Pediatric Refractory/Relapsed ALL

January 28, 2005

Contracting Dispute and Software Bugs Plague NCI’s $200 Million Bioinformatics Venture

February 25, 2011

Scrutiny of caBIG Exposes Conflicts, Bonanza For Contractors

March 18, 2011

Varmus’s 2016 Bypass Budget Seeks “Modest” Increase of $823 Million

December 5, 2014

Clinical Trials: Data Manager Falsified NSABP Records On 3 Patients, ORI Says

February 12, 1999